BIOLOGICAL INTERACTIONS OF EXTRACELLULAR VESICLES CONTRIBUTING TO METASTASIS OF BREAST CANCER AND OSTEOSARCOMA
Raluca Ghebosu, PhD Candidate
Australian Institute for Bioengineering and Nanotechnology
University of Queensland, Brisbane, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Queensland, Australia | October 2024
Raluca Ghebosu graduated from the University of Queensland with a Bachelor of Arts/Bachelor of Science with majors in Japanese and Biomedical Science (2018-2021). She then completed her Bachelor of Science (Honours) with the School of Biomedical Sciences at the University of Queensland in 2022, before pursuing a PhD with A/Prof. Joy Wolfram at the Australian Institute for Bioengineering and Nanotechnology.
Raluca is currently exploring the complex biological interactions of extracellular vesicles, with the goal of understanding how they can contribute to the metastasis of breast cancer and osteosarcoma. She will do this by uncovering how extracellular vesicles from breast cancer and osteosarcoma cells allow the cancer cells to evade the immune system and avoid being detected by Natural Killer cells. By shedding light on the complex role of extracellular vesicles in cancer metastasis she hopes to revolutionise nanoparticle and cell-based cancer treatments.
Since beginning her PhD in 2023, Raluca has published two first author and two co-author manuscripts in high-ranking journals, including a first author paper in the premier journal of her field, Journal of Extracellular Vesicles (IF: 15.5), and has gained over 500 citations across her publications. She has presented her work to various audiences including scientists, clinicians and consumers and is a University of Queensland, 2024 3 Minute Thesis finalist. Raluca is also involved with the Wonder of Science Outreach program that promotes scientific inquiry and engagement to school-aged students across Queensland. Raluca hopes to continue being an advocate for STEM education and sharing her work with consumers and the broader scientific community
https://orcid.org/0000-0001-8839-3512
-
Superslayer taking on antibiotic-resistant bacteria
Dr Katharina Richter is a visionary leader in MedTech, acclaimed for innovation and gender diversity. With over 40 awards to her name, including MIT Innovator Under 35 Asia-Pacific, and Prime Minister’s Prize for New Innovator finalist, she has shattered barriers as an entrepreneur, scientist, and ‘superbug slayer.’ Katharina’s groundbreaking work in combating antibiotic-resistant bacteria has resulted in 6 innovative treatments, 3 of which are patented, offering hope against deadly infections.
-
Trials in treating STIs, vaccines and lipid lowering medications
Since joining Paratus Clinical Research in 2022, Dr Pi Lip Seet has served as both Principal Investigator and Sub-Investigator across Phase I–IV industry-sponsored clinical trials. His research experience spans vaccines, immunology, cardiovascular and endocrine disease, respiratory medicine, gastroenterology, pain management, sleep medicine and adult psychiatry. He has been involved in multiple vaccine development programs, including RSV, influenza, COVID-19, herpes zoster and pneumococcal studies.
-
Clinical Research in Emergency Medicine
Professor Daniel Fatovich is a senior emergency physician and clinical researcher at Royal Perth Hospital Emergency Department (ED), with over 30 years’ experience in the design and conduct of clinical research in Emergency Medicine. He is also Head of the Centre for Clinical Research in Emergency Medicine (CCREM) within the Harry Perkins Institute of Medical Research.
